WHITEHAWK THERAPEUTICS, INC. — Net Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8769a3e3-cf04-44b1-b518-0ec8fdf01f1b/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-20.6M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-104158 |
| FY 2024 | $-63.7M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-015269 |
| FY 2023 | $-65.8M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-010901 |
| FY 2022 | $-60.5M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-009583 |
| FY 2021 | $-110.1M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-010721 |
| FY 2020 | $-3.5M | 2020-01-01 – 2020-12-31 | evidence 0001564590-22-010721 |
| FY 2019 | $-23.3M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-011174 |
| FY 2018 | $-10.4M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006602 |
| FY 2017 | $-21.4M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005868 |
| FY 2016 | $-17.0M | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-005868 |
| FY 2015 | $-31.4k | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-012024 |
| FY 2014 | $-30.8k | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-001427 |
| FY 2013 | $-180.0k | 2007-11-16 – 2014-03-31 | evidence 0001213900-14-003351 |
| FY 2012 | $-151.6k | 2007-11-16 – 2013-03-31 | evidence 0001144204-13-029407 |
| FY 2011 | $-123.5k | 2007-11-16 – 2012-03-31 | evidence 0001144204-12-029112 |
| FY 2010 | $-22.4k | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-018750 |
| FY 2009 | $-20.0k | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-018750 |
| FY 2008 | $-33.6k | 2008-01-01 – 2008-12-31 | evidence 0001144204-12-018750 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
WHITEHAWK THERAPEUTICS, INC. — all facts · Revenue · Operating Income